

Service Human Health

Shenzhen Dake Medical Technology Co., Ltd.
Shenzhen Dake Medical Technology Co., Ltd. is located in Shenzhen, a beautiful city of innovation. We are a high-tech enterprise integrating the R&D, manufacturing, sales and technical support of in vitro diagnostics instruments and reagents, with core business in immunoassay chemiluminescence and clinical chemistry instruments, reagents and related supporting products. Committed to the philosophy of "serving human health", Dake moves forward with the spirit of "innovation-driven progress" to create a future of boundless promise.
Dake Medical focuses on instruments, reagents and related supporting business in chemiluminescence immunoassay and HPLC HbA1c. In immunoassay, we have developed and obtained registration for 60, 100, 600 and 900 tests/hour fully automated chemiluminescence immunoassay analyzers, together with matching registered test items for cardiac, infection, thyroid function, hormone, tumor marker, anemia and bone metabolism, and glucose metabolism. These include distinctive assays such as vitamins, ST2 and Lp-PLA2. For HbA1c, we have developed and obtained registration for 60, 80 and 120 tests/hour fully automated HPLC HbA1c analyzers and matching reagents.
Dake attaches great importance to R&D investment, which accounts for more than 45%. We have been granted 5 invention patents, 2 utility model patents, 1 design patent and 9 software copyrights, and have been recognized as a Technology-based SME and a National High-tech Enterprise.
Dake is committed to the philosophy of "serving human health" and, with the spirit of "innovation-driven progress", creates a future of boundless promise.
What drives us
Innovation-driven, safeguarding health, dedicated service, pioneering through action
To be a core force in serving human health
Innovation drives progress and shapes the future of humanity
Customer Service, Perseverance, Courage to Innovate
The name Dake comes from the idea of boundless promise. We built a nearly 2,000 m² R&D center and GMP manufacturing center, officially starting our journey in the IVD industry.
Completed development of the Bright i60, Bright i100, Bright i600 and Bright i1200 series chemiluminescence instruments, along with 25 reagent products.
Completed development of chemiluminescence reagents and HbA1c instruments and reagents; filed 22 patent applications, including invention patents, utility models, designs and software copyrights.
24 reagent products and 1 instrument product obtained registration and were launched; 4 invention patents, 2 utility model patents, 1 design patent and 9 software copyrights were granted. Recognized as a Technology-based SME and a National High-tech Enterprise.
3 chemiluminescence instrument products and 29 reagent products, including 3 Class III products, obtained registration and were launched; HbA1c instruments and reagent products obtained registration and were launched; 1 invention patent and 4 software copyrights were granted, and we passed ISO 13485 medical device quality management system certification; R&D was started on more than 30 chemiluminescence reagent products.

From September 21 to 23, the 2026 Shenzhen International High-Performance Medical Device Exhibition and Innovative Pharmaceutical Exhibition took place, with more than 300 companies from across the industry chain exhibiting. At Booth 01C18 in the Guangming District pavilion, Dake Medical presented its chemiluminescence immunoassay and HbA1c platform analyzers together with matching reagents — three days of conversations and reflections.

Shenzhen Dake Medical Technology Co., Ltd. focuses on the R&D, production, sales and technical support of in vitro diagnostic instruments and reagents. It has developed and registered a full series of chemiluminescence immunoassay and HPLC-based HbA1c products. This article reviews Dake Medical's growth path, business layout and integrated core advantages.